French biotechnology company founded in 2017, developing innovative therapeutic solutions for glaucoma in ophthalmology.
Ciliatech is a French biotechnology company founded in 2017 that develops innovative solutions for the treatment of glaucoma in ophthalmology. Based in France, the company concentrates its work on glaucoma therapeutics, a field concerned with lowering intraocular pressure and preventing the progressive loss of sight associated with the disease.
The company's technical focus spans ophthalmology, biotechnology and glaucoma therapeutics, within the broader healthcare and pharmaceutical sectors. Ciliatech describes its mission as restoring sight and transforming ocular care, and states a commitment to making a difference in patients' lives.
Ciliatech characterises itself as a team of innovators drawn from various countries and backgrounds, and says it embraces an international perspective across its workforce. The company maintains a web presence at cilia.tech.
